David Kirn, Chief Executive Officer at 4D Molecular Therapeutics, Inc. (FDMT), sold 12,930 shares at $23.10 ($299K) on 2024-06-24, disclosed to the SEC on 2024-06-26.
Scheduled sale ($299k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| FDMT | SELL | 2026-08-21 | $1.1M | — | Filing → |
| FDMT | SELL | 2026-08-05 | $275K | — | Filing → |
| FDMT | SELL | 2026-08-04 | $125K | — | Filing → |